BLA
IOVA icon

Balter Liquid Alternatives’s Iovance Biotherapeutics IOVA Stock Holding History

Balter Liquid Alternatives’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,254
Closed -$138K – 234
2018
Q3 		$138K Hold
12,254
– – 0.11% 159
2018
Q2 		$163K Buy
12,254
+1,588
+15% +$23.2K 0.13% 163
2018
Q1 		$180K Sell
10,666
-13,508
-56% -$205K 0.17% 142
2017
Q4 		$193K Buy
24,174
+1,565
+7% +$12.6K 0.19% 128
2017
Q3 		$175K Buy
22,609
+10,936
+94% +$69.2K 0.2% 123
2017
Q2 		$86K Buy
+11,673
New +$74.2K 0.1% 124

Other funds holding IOVA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return